Supplementary Figure from Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication

Authors :: Sharyn D. Baker
Stanley Pounds
Jeffrey E. Rubnitz
Raul C. Ribeiro
Ching-Hon Pui
Sheila Shurtleff
James S. Blachly
Daelynn R. Buelow
Lie Li
John C. Panetta
Jolieke G. van Oosterwijk
Hiroto Inaba
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figure from Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication

Tools